Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zaltrap in Platinum- and Erlotinib-resistant NSCLC
NCT00284141Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of aflibercept in lung adenocarcinoma, sponsored by Sanofi. Started Jan 2006; status: completed.
02
Drugs
aflibercept
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00284141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284141.